In addition, the levels of CD44 gene methylation alone, or in a relevant gene methylation panel from tumor or cell free DNA, could be employed as a prognostic marker in ccRCC, where relevant to tumor aggressiveness [26]. This evidence concerns the gene CD44 and neoplasm.